| Dr Brian J Taylor, MD | |
|
13515 Wolfe Rd, Suite C, New Freedom, PA 17349-9346 | |
| (717) 812-2501 | |
| (717) 416-7178 |
| Full Name | Dr Brian J Taylor |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 26 Years |
| Location | 13515 Wolfe Rd, New Freedom, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437185212 | NPI | - | NPPES |
| 50061850 | Other | PA | CAPITAL BLUE CROSS-WMG SV |
| 7241864 | Other | PA | AETNA |
| P006502 | Other | PA | GATEWAY-WMG |
| 100989 | Other | PA | GEISINGER |
| 101542140 | Medicaid | PA | |
| 20064071 | Other | PA | AH MERCY-WMG READYCARE |
| 50062688 | Other | PA | CAPITAL BLUE CROSS-WMG RE |
| 1844228 | Other | PA | HIGHMARK BLUE SHIELD |
| 1553246 | Other | PA | GATEWAY-WMG WRC |
| 102863 | Other | PA | JOHNS HOPKINS |
| 186365 | Other | PA | UNISON-WMG SVFM |
| 30153623 | Other | PA | AMERIHEALTH CARITAS PA - WMG - THFPC |
| 189958 | Other | PA | UNISON-WMG READYCARE |
| 20055992 | Other | PA | AH MERCY-WMG SVFM |
| 2161250 | Other | PA | MAMSI-WMG READYCARE |
| 884955 | Other | MD | CAREFIRST MARYLAND BCBS |
| 2147311 | Other | PA | MAMSI-WMG SVFM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD428025 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellspan Vna Home Care | York, PA | Home health agency |
| Hospice And Community Care | Lancaster, PA | Hospice |
| York Hospital | York, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellspan Medical Group | 1951213115 | 1946 |
News Archive
A new study indicates that red meat intake may increase the risk of kidney failure in the general population, and substituting red meat with alternative sources of protein from time to time may significantly reduce this risk.
A large proportion of the American public opts to receive cancer screenings with the hope that testing will reduce their chance of cancer death.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD), announced today that results from the Phase III EINSTEIN-Extension (EXT) clinical trial of the novel oral anticoagulant rivaroxaban showed a significant reduction in the risk of recurrent symptomatic venous thromboembolism (VTE), compared to placebo, in patients who have been treated for a previous deep vein thrombosis (DVT) or pulmonary embolism (PE).
Countless microorganisms live in the intestinal tract. Researchers at the Technical University of Munich have been able to demonstrate that intestinal bacteria also play a role in determining the strength of anaphylactic reactions to food allergens.
› Verified 9 days ago
| Entity Name | York Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326060492 PECOS PAC ID: 2961307467 Enrollment ID: O20031205000629 |
News Archive
A new study indicates that red meat intake may increase the risk of kidney failure in the general population, and substituting red meat with alternative sources of protein from time to time may significantly reduce this risk.
A large proportion of the American public opts to receive cancer screenings with the hope that testing will reduce their chance of cancer death.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD), announced today that results from the Phase III EINSTEIN-Extension (EXT) clinical trial of the novel oral anticoagulant rivaroxaban showed a significant reduction in the risk of recurrent symptomatic venous thromboembolism (VTE), compared to placebo, in patients who have been treated for a previous deep vein thrombosis (DVT) or pulmonary embolism (PE).
Countless microorganisms live in the intestinal tract. Researchers at the Technical University of Munich have been able to demonstrate that intestinal bacteria also play a role in determining the strength of anaphylactic reactions to food allergens.
› Verified 9 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
A new study indicates that red meat intake may increase the risk of kidney failure in the general population, and substituting red meat with alternative sources of protein from time to time may significantly reduce this risk.
A large proportion of the American public opts to receive cancer screenings with the hope that testing will reduce their chance of cancer death.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD), announced today that results from the Phase III EINSTEIN-Extension (EXT) clinical trial of the novel oral anticoagulant rivaroxaban showed a significant reduction in the risk of recurrent symptomatic venous thromboembolism (VTE), compared to placebo, in patients who have been treated for a previous deep vein thrombosis (DVT) or pulmonary embolism (PE).
Countless microorganisms live in the intestinal tract. Researchers at the Technical University of Munich have been able to demonstrate that intestinal bacteria also play a role in determining the strength of anaphylactic reactions to food allergens.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian J Taylor, MD 3421 Concord Rd, York, PA 17402-9001 Ph: (717) 812-2501 | Dr Brian J Taylor, MD 13515 Wolfe Rd, Suite C, New Freedom, PA 17349-9346 Ph: (717) 812-2501 |
News Archive
A new study indicates that red meat intake may increase the risk of kidney failure in the general population, and substituting red meat with alternative sources of protein from time to time may significantly reduce this risk.
A large proportion of the American public opts to receive cancer screenings with the hope that testing will reduce their chance of cancer death.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD), announced today that results from the Phase III EINSTEIN-Extension (EXT) clinical trial of the novel oral anticoagulant rivaroxaban showed a significant reduction in the risk of recurrent symptomatic venous thromboembolism (VTE), compared to placebo, in patients who have been treated for a previous deep vein thrombosis (DVT) or pulmonary embolism (PE).
Countless microorganisms live in the intestinal tract. Researchers at the Technical University of Munich have been able to demonstrate that intestinal bacteria also play a role in determining the strength of anaphylactic reactions to food allergens.
› Verified 9 days ago
Dr. Nicholas Adam Lumsden, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13515 Wolfe Rd, Ste C, New Freedom, PA 17349 Phone: 717-812-2501 Fax: 717-461-7178 | |
Samuel Boateng, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13515 Wolfe Rd Ste C, New Freedom, PA 17349 Phone: 717-812-2501 Fax: 717-461-7178 | |
Amara Zubair Burney, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13515 Wolfe Rd, Suite C, New Freedom, PA 17349 Phone: 717-812-2501 Fax: 717-812-2510 | |
Patricia Chen, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 13515 Wolfe Rd Ste C, New Freedom, PA 17349 Phone: 717-812-2501 | |
Dr. Michelle Lorraine Schlosser, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13515 Wolfe Rd, Suite C, New Freedom, PA 17349 Phone: 717-812-2501 Fax: 717-461-7178 | |
Dr. Douglas H Prince, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13515 Wolfe Rd, Suite C, New Freedom, PA 17349 Phone: 717-812-2501 Fax: 717-461-7178 |